Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay

Fertility and Sterility

Volumn 102, Issue 2, 2014, Pages 483-487

  Decanter, Christine ^a   Peigne, Maeliss ^a   Mailliez, Audrey ^b   Morschhauser, Franck ^a   Dassonneville, Audrey ^a   Dewailly, Didier ^a   Pigny, Pascal ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

AMH; cancer; chemotherapy; follow up; ovarian follicles

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINDESINE;

ADULT; AMENORRHEA; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERSENSITIVE PICOANTIMULLERIAN HORMONE ASSAY; IMMUNOASSAY; LYMPHOMA; MEASUREMENT PRECISION; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; OVARIAN RESERVE; OVARY FOLLICLE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

AMH; CANCER; CHEMOTHERAPY; FOLLOW-UP; OVARIAN FOLLICLES;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AMENORRHEA; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MENSTRUATION; MULTIVARIATE ANALYSIS; OVARY; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84905500431     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.05.014     Document Type: Article

References (26)

1. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio et al. AMH as a predictive marker in assisted reproductive technology Hum Reprod Update 16 2010 113 130
2. D. Dewailly, C.Y. Andersen, A. Balen, F. Broekmans, N. Dilaver, and R. Fanchin et al. The physiology and clinical utility of AMH in women Hum Reprod Update 20 2014 370 385
3. C. Weenen, J.S. Laven, A.R. Von Bergh, M. Cranfield, N.P. Groome, and J.A. Visser et al. AMH expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Hum Reprod 10 2004 77 83
4. J.V. Jeppensen, R.A. Anderson, T.W. Kelsey, S.L. Christiansen, S.G. Kristelsen, and K. Jayaprakasan et al. Which follicles make the most AMH in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection Mol Hum Reprod 19 2013 519 527
5. H. Roness, Z. Gavish, Y. Cohen, and D. Meirow Ovarian follicle burnout a universal phenomenon? Cell Cycle 12 2013 3245 3246
6. S. Morgan, R.A. Anderson, C. Gourley, W.H. Wallace, and N. Spears How do chemotherapeutic agents damage the ovary? Hum Reprod Update 18 2012 525 535
7. R.A. Anderson, and D.A. Cameron Pretreatment serum AMH predicts long term ovarian function and bone mass after chemotherapy for early breast cancer J Clin Endocrinol Metab 96 2011 1336 1343
8. R.A. Anderson, M. Rosendahl, T.W. Kelsey, and D.A. Cameron Pretreatment AMH predicts for loss of ovarian function after chemotherapy for early breast cancer Eur J Cancer 49 2013 3404 3411
9. K.E. Dillon, M.D. Sammel, M. Prewitt, J.P. Ginsberg, D. Walker, and J.E. Mersereau et al. Pretreatment AMH levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy Fertil Steril 99 2013 477 483
10. M. Rosendahl, M.T. Andersen, E. Ralkiaer, L. Kjeldsen, M.K. Andersen, and C.Y. Andersen Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia Fertil Steril 94 2010 2186 2190
11. L.E. Bath, W.H. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by AMH, inhibin B and ovarian ultrasound Hum Reprod 18 2003 2368 2374
12. A.H. Partridge, K.J. Ruddy, S. Gelber, L. Shapira, M. Abusief, and M. Meyer et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertil Steril 94 2010 638 644
13. M.R. Sowers, A.D. Eyvazzadeh, D. McConnell, M. Yosef, M.L. Jannausch, and D. Zhang et al. AMH and inhibin B in the definition of ovarian aging and the menopause transition J Clin Endocrinol Metab 93 2008 3478 3483
14. S.L. Broer, M.J. Eijkemans, G.J. Scheffer, I.A. Van Rooij, A. de Vet, and A.P. Themmen et al. AMH predicts menopause: a long term follow up study in normoovulatory women J Clin Endocrinol Metab 96 2011 2532 2539
15. M. Peigné, and C. Decanter Serum AMH level as a marker of acute and long term effects of chemotherapy on the ovarian follicular content: a systematic review Reprod Biol Endocrinol 12 2014 26
16. C. Decanter, F. Morschhauser, P. Pigny, C. Lefebvre, C. Gallo, and D. Dewailly AMH follow-up in young women treated by chemotherapy for lymphoma: preliminary results Reprod Biomed Online 20 2010 280 285
17. R.A. Anderson, A.P. Themmen, A. Al Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum Reprod 21 2006 2583 2592
18. A. Kumar, B. Kaira, A. Patel, L. Mc David, and W.E. Roudebush Development of a second generation AMH ELISA J Immunol Methods 362 2010 51 59
19. W.Q. Long, V. Ranchin, P. Pautier, C. Belville, P. Denizot, and H. Cailla et al. Detection of minimal levels of serum AMH during follow up of patients with ovarian granulose cell tumor by means of a highly sensitive ELISA J Clin Endocrinol Metab 85 2000 540 544
20. K. Chung, F. Stanczyk, L. Ma, M. Sammel, C. Haunschild, and I. Su Can ultrasensitive AMH assays detect ovarian function in older reproductive-aged women with breast cancer? (abstract P55) Fertil Steril 100 2013 S164
21. R. Fleming, C. Fairbairn, D. Lucas, M. Gaudoin, and R.A. Anderson Analysis of two assays for the measurement of AMH in women with low ovarian reserve (abstract P48) Fertil Steril 100 2013 S162
22. H. Hamre, C.E. Kiserud, E. Rudd, P.M. Thorsby, and S.D. Fossa Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study Pediatr Blood Cancer 59 2012 271 277
23. J.M. Letourneau, E.E. Ebbel, P.P. Katz, A. Katz, W.Z. Ai, and A.J. Chien et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer Cancer 118 2012 1710 1717
24. M.F. Brougham, P.M. Crofton, E.J. Johnson, N. Evans, R.A. Anderson, and W.H. Wallace AMH is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study J Clin Endocrinol Metab 97 2012 2059 2067
25. S.M. Nelson AMH: is the writing on the wall for antral follicle count? Fertil Steril 99 2013 1563 1564
26. T. Greve, K.T. Schmidt, S.G. Kristensen, E. Ernst, and C.Y. Andersen Evaluation of the ovarian reserve in women transplantated with frozen and thawed ovarian cortical tissue Fertil Steril 97 2012 1394 1398